CorMedix Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
2.00
189.30
210.10
224.10
329.30
429.80
Cost of Goods Sold (COGS) incl. D&A
206.80
460.90
333.80
392.30
151.90
471
Gross Income
204.80
271.60
123.70
168.20
177.50
41.20
SG&A Expense
4,710.60
8,630.50
16,530.30
24,592.80
33,101.60
26,823
EBIT
4,915.40
8,902.10
16,654.00
24,760.90
32,924.10
26,864.20
Unusual Expense
2,769.50
11,401.10
-
-
177.10
-
Non Operating Income/Expense
4.50
150.80
1,590.00
9.50
19.40
0.20
Interest Expense
1,444.40
2.10
4.00
-
-
1.90
Pretax Income
9,133.10
20,453.40
18,187.50
24,643.60
33,009.90
26,829.60
Consolidated Net Income
9,133.10
20,453.40
18,187.50
24,643.60
33,009.90
26,829.60
Net Income
9,133.10
20,453.40
18,187.50
24,643.60
33,009.90
26,829.60
Net Income After Extraordinaries
9,133.10
20,453.40
18,187.50
24,643.60
33,009.90
26,829.60
Net Income Available to Common
9,517.40
20,536.30
18,220.70
24,643.60
33,009.90
26,829.60
EPS (Basic)
0.69
0.96
0.58
0.65
0.60
1.51
Basic Shares Outstanding
13,823.10
21,441.90
31,343.50
37,967.40
55,141.10
17,816.60
EPS (Diluted)
0.69
0.96
0.58
0.65
0.60
1.51
Diluted Shares Outstanding
13,823.10
21,441.90
31,343.50
37,967.40
55,141.10
17,816.60
EBITDA
4,910.20
8,887.10
16,638.90
24,735.30
32,887.20
26,790
Non-Operating Interest Income
0.70
2.70
60.40
126.80
110.70
36.60
Preferred Dividends
384.30
82.90
33.10
-
-
-
About CorMedix
View Profile
